Company intelligence / Profile preview

Ageless Biotech

Las Vegas, Nevada, United Statesagelessbiotech.com ↗

Ownership: Private
Employees: ~10
Development stage: Phase 2

Overview

Ageless Biotech has an FDA Investigational New Drug Application (IND) accepted for a Phase IIb study targeting moderate-to-severe osteoarthritis of the knee. The product uses minimally manipulated adipose-derived stem cells processed via a proprietary SVF method. The company aims to demonstrate both safety and efficacy with minimal patient downtime, positioning its therapy as a potential alternative to surgery. No published clinical results yet; trials are ongoing or recently initiated as of early 2022–2023.

Therapeutic areas: Rheumatology
Modalities: Stem cell therapy (adipose-derived stem cells, umbilical tissue-based biologics)
Industry: Biotech

Drug pipeline

1 asset

OA-SYS

Partnerships

SimonMed Imaging – partnership to use advanced MRI imaging in clinical trials for osteoarthritis treatment assessmentCollaboration with a team including regulatory experts with extensive FDA experience, but no major pharma partnerships disclosed.

Beyond the preview

Go deeper on Ageless Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ageless Biotech.

Explore the full profile